SCHEMBL8423263

SCHEMBL8423263

O=C(SCCS)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.46
GSK3B P49841 2/20 0.43
PTPN1 P18031 1/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA3 P07451 1/20 0.43
CA4 P22748 1/20 0.43
CA6 P23280 1/20 0.43
CA5A P35218 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CA13 Q8N1Q1 1/20 0.43
CA14 Q9ULX7 1/20 0.43
CA5B Q9Y2D0 1/20 0.43
GPR139 Q6DWJ6 1/20 0.42
CES1 P23141 4/20 0.41
MAPT P10636 3/20 0.41
MAPK1 P28482 2/20 0.41
CYP3A4 P08684 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16047247 0.87 KMT2A (0.52) KMT2AGSK3BPTPN1CA12CA1
SCHEMBL8424913 0.85 HDAC3 (0.51) KMT2AGSK3BPTPN1CA12CA1
SCHEMBL7909243 0.83 KMT2A (0.49) KMT2AGSK3BPTPN1CA12CA1
SCHEMBL31131464 0.83 KMT2A (0.49) KMT2AGSK3BPTPN1CA12CA1
SCHEMBL10952894 0.81 GSK3B (0.50) KMT2AGSK3BPTPN1CA12CA1
SCHEMBL6830395 0.81 KMT2A (0.47) KMT2AGSK3BPTPN1CA12CA1
SCHEMBL6549496 0.79 IDO1 (0.53) KMT2AGSK3BPTPN1GPR139CES1
SCHEMBL22616327 0.79 KMT2A (0.46) KMT2AGSK3BPTPN1CA12CA1
SCHEMBL6057351 0.79 KMT2A (0.50) KMT2AGSK3BPTPN1GPR139CES1
SCHEMBL6057430 0.79 ALDH1A1 (0.48) KMT2AGSK3BPTPN1GPR139CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3728591-B1 GAPMER OLIGONUCLEOTIDES COMPRISING A PHOSPHORODITHIOATE INTERNUCLEOSIDE LINKAGE ROCHE INNOVATION CT COPENHAGEN AS (DK) 2025-07-23 EP disclosed
EP-3728590-B1 NOVEL THIOPHOSPHORAMIDITES ROCHE INNOVATION CT COPENHAGEN AS (DK) 2025-07-02 EP disclosed
CN-111448316-B Novel thiophosphorous acid amides 罗氏创新中心哥本哈根有限公司 2025-02-14 CN disclosed
US-20240368593-A1 GAPMER OLIGONUCLEOTIDES COMPRISING A PHOSPHORODITHIOATE INTERNUCLEOSIDE LINKAGE ROCHE INNOVATION CENTER COPENHAGEN A/S (DK) 2024-11-07 US disclosed
EP-3728592-B1 OLIGONUCLEOTIDES COMPRISING A PHOSPHORODITHIOATE INTERNUCLEOSIDE LINKAGE ROCHE INNOVATION CT COPENHAGEN AS (DK) 2024-05-29 EP disclosed
US-11597926-B2 Thiophosphoramidites ROCHE INNOVATION CENTER COPENHAGEN A/S (DK) 2023-03-07 US disclosed
US-11597926-B2 Thiophosphoramidites ROCHE INNOVATION CENTER COPENHAGEN A/S (DK) 2023-03-07 US disclosed
US-20230002762-A1 OLIGONUCLEOTIDES COMPRISING A PHOSPHORODITHIOATE INTERNUCLEOSIDE LINKAGE ROCHE INNOVATION CENTER COPENHAGEN A/S (DK) 2023-01-05 US disclosed
US-20230002762-A1 OLIGONUCLEOTIDES COMPRISING A PHOSPHORODITHIOATE INTERNUCLEOSIDE LINKAGE ROCHE INNOVATION CENTER COPENHAGEN A/S (DK) 2023-01-05 US disclosed
EP-4092117-A1 GAPMER OLIGONUCLEOTIDES COMPRISING A PHOSPHORODITHIOATE INTERNUCLEOSIDE LINKAGE Roche Innovation Center Copenhagen A/S (DK) 2022-11-23 EP disclosed
US-20200339982-A1 OLIGONUCLEOTIDES COMPRISING A PHOSPHORODITHIOATE INTERNUCLEOSIDE LINKAGE ROCHE INNOVATION CENTER COPENHAGEN A/S (DK) 2020-10-29 US disclosed
EP-3728590-A1 NOVEL THIOPHOSPHORAMIDITES Roche Innovation Center Copenhagen A/S (DK) 2020-10-28 EP disclosed
EP-3728592-A1 OLIGONUCLEOTIDES COMPRISING A PHOSPHORODITHIOATE INTERNUCLEOSIDE LINKAGE Roche Innovation Center Copenhagen A/S (DK) 2020-10-28 EP disclosed
EP-3728591-A1 GAPMER OLIGONUCLEOTIDES COMPRISING A PHOSPHORODITHIOATE INTERNUCLEOSIDE LINKAGE Roche Innovation Center Copenhagen A/S (DK) 2020-10-28 EP disclosed
US-20200332289-A1 GAPMER OLIGONUCLEOTIDES COMPRISING A PHOSPHORODITHIOATE INTERNUCLEOSIDE LINKAGE ROCHE INNOVATION CENTER COPENHAGEN A/S (DK) 2020-10-22 US disclosed
US-20200332289-A1 GAPMER OLIGONUCLEOTIDES COMPRISING A PHOSPHORODITHIOATE INTERNUCLEOSIDE LINKAGE ROCHE INNOVATION CENTER COPENHAGEN A/S (DK) 2020-10-22 US disclosed
CN-111448316-A Novel thiophosphorous acid amides 罗氏创新中心哥本哈根有限公司 2020-07-24 CN disclosed
EP-0757060-B1 Process for producing vinyl alcohol polymer KURARAY CO (JP) 1999-10-20 EP disclosed
US-5710211-A REACTION OF POLYMER WITH COMPOUND HAVING A THIOL OR THIOESTER AND HYDROLYSIS TO FORM VINYL ALCOHOL KURARAY CO., LTD. (JP) 1998-01-20 US disclosed
EP-0757060-A2 Process for producing vinyl alcohol polymer KURARAY CO., LTD. (JP) 1997-02-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002762-A1 OLIGONUCLEOTIDES COMPRISING A PHOSPHORODITHIOATE INTERNUCLEOSIDE LINKAGE DUT, TYMP, TYMS KMT2A 2877/4885GSK3B 3837/4885PTPN1 2570/4885
US-20200339982-A1 OLIGONUCLEOTIDES COMPRISING A PHOSPHORODITHIOATE INTERNUCLEOSIDE LINKAGE DUT, TYMP, TYMS KMT2A 2807/4885GSK3B 3948/4885PTPN1 2430/4885
US-11597926-B2 Thiophosphoramidites TYMP, RRM2B, RRM2 KMT2A 1594/4885GSK3B 2117/4885PTPN1 454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.